Search results
Added:
2 months ago
ACC 2025 - Outcomes from colchicine in patients with stable coronary artery disease (CAD) shows significant plaque volume progression compared to placebo at one year.Dr Matthew Budoff (UCLA Medical Centre, Los Angeles, US) joins us onsite at ACC 2025 to discuss findings from the randomized, placebo-controlled, investigator-initiated EKSTROM trial (NCT06342609; Lundquist Institute for Biomedical…
View more
Management of CAD in TAVI
Added:
2 days ago
Article
Added:
9 months ago
Added:
1 month ago
TCT Middle East 2025 — We are joined by Dr Nouf Alanazi, Dr Alaide Chieffo and Dr Nadia Sutton as they discuss key takeaways from the conference for the physiological assessment of coronary artery disease.The panel explores emerging paradigms in MINOCA and INOCA management, addressing the limitations of conventional approaches. They review current guideline recommendations for functional testing…
View more
Added:
1 month ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II…
View more
Added:
1 year ago
Added:
6 months ago
Added:
8 months ago
With focus on the 2024 ESC chronic coronary syndromes (CCS) guidelines – that highlighted significant advancements in the recommendations for fractional flow reserve computed tomography (FFRct) and coronary computed tomography angiography (CTA) – this insightful series aims to equip healthcare professionals with the latest clinical strategies and practical tools for integrating FFRct and coronary…
View more
Added:
4 months ago
Added:
1 year ago
